{
    "symbol": "AMRX",
    "quarter": 1,
    "year": 2022,
    "date": "2022-05-04 14:04:01",
    "content": " As our pipeline delivers new branded products, including  and DHE this year and IPX-203 next year, we see a Specialty business expanding very meaningfully over the next several years. And I think more are being available with this biotech pool in the market and other conditions which are driving companies like us in a better of a driver's seat because of the constant cash flow from our Generics business, Injectables business, Specialty business allows us to sustain our growth and keep adding these assets."
}